LHYFE SAS (LHYFE.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:LHYFE • FR0014009YQ1

2.833 EUR
-0.02 (-0.6%)
Last: Feb 10, 2026, 02:46 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

LHYFE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 74 industry peers in the Oil, Gas & Consumable Fuels industry. LHYFE has a bad profitability rating. Also its financial health evaluation is rather negative. LHYFE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year LHYFE has reported negative net income.
  • LHYFE had a negative operating cash flow in the past year.
  • LHYFE had negative earnings in each of the past 5 years.
  • LHYFE had a negative operating cash flow in each of the past 5 years.
LHYFE.PA Yearly Net Income VS EBIT VS OCF VS FCFLHYFE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • LHYFE's Return On Assets of -15.49% is on the low side compared to the rest of the industry. LHYFE is outperformed by 91.89% of its industry peers.
  • With a Return On Equity value of -72.30%, LHYFE is not doing good in the industry: 93.24% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -15.49%
ROE -72.3%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-15.02%
ROE(3y)-30.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LHYFE.PA Yearly ROA, ROE, ROICLHYFE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • LHYFE has a better Gross Margin (80.73%) than 87.84% of its industry peers.
  • In the last couple of years the Gross Margin of LHYFE has grown nicely.
  • The Profit Margin and Operating Margin are not available for LHYFE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.82%
GM growth 5YN/A
LHYFE.PA Yearly Profit, Operating, Gross MarginsLHYFE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K -50K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • LHYFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, LHYFE has about the same amount of shares outstanding.
  • Compared to 5 years ago, LHYFE has more shares outstanding
  • Compared to 1 year ago, LHYFE has a worse debt to assets ratio.
LHYFE.PA Yearly Shares OutstandingLHYFE.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LHYFE.PA Yearly Total Debt VS Total AssetsLHYFE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -0.49, we must say that LHYFE is in the distress zone and has some risk of bankruptcy.
  • LHYFE's Altman-Z score of -0.49 is on the low side compared to the rest of the industry. LHYFE is outperformed by 86.49% of its industry peers.
  • A Debt/Equity ratio of 1.55 is on the high side and indicates that LHYFE has dependencies on debt financing.
  • LHYFE's Debt to Equity ratio of 1.55 is on the low side compared to the rest of the industry. LHYFE is outperformed by 83.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Altman-Z -0.49
ROIC/WACCN/A
WACC7.44%
LHYFE.PA Yearly LT Debt VS Equity VS FCFLHYFE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • LHYFE has a Current Ratio of 1.69. This is a normal value and indicates that LHYFE is financially healthy and should not expect problems in meeting its short term obligations.
  • LHYFE's Current ratio of 1.69 is fine compared to the rest of the industry. LHYFE outperforms 72.97% of its industry peers.
  • A Quick Ratio of 1.68 indicates that LHYFE should not have too much problems paying its short term obligations.
  • The Quick ratio of LHYFE (1.68) is better than 79.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.68
LHYFE.PA Yearly Current Assets VS Current LiabilitesLHYFE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • LHYFE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.15%.
  • Looking at the last year, LHYFE shows a very strong growth in Revenue. The Revenue has grown by 209.99%.
  • Measured over the past years, LHYFE shows a very strong growth in Revenue. The Revenue has been growing by 195.81% on average per year.
EPS 1Y (TTM)-16.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.16%
Revenue 1Y (TTM)209.99%
Revenue growth 3Y195.81%
Revenue growth 5YN/A
Sales Q2Q%177.45%

3.2 Future

  • Based on estimates for the next years, LHYFE will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.93% on average per year.
  • LHYFE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 129.95% yearly.
EPS Next Y-6.77%
EPS Next 2Y11.86%
EPS Next 3Y12.93%
EPS Next 5YN/A
Revenue Next Year111.33%
Revenue Next 2Y290.88%
Revenue Next 3Y183.6%
Revenue Next 5Y129.95%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LHYFE.PA Yearly Revenue VS EstimatesLHYFE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
LHYFE.PA Yearly EPS VS EstimatesLHYFE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • LHYFE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LHYFE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LHYFE.PA Price Earnings VS Forward Price EarningsLHYFE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LHYFE.PA Per share dataLHYFE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • LHYFE's earnings are expected to grow with 12.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.86%
EPS Next 3Y12.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LHYFE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LHYFE SAS

EPA:LHYFE (2/10/2026, 2:46:29 PM)

2.833

-0.02 (-0.6%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-03
Earnings (Next)03-31
Inst Owners8.47%
Inst Owner ChangeN/A
Ins Owners21.3%
Ins Owner ChangeN/A
Market Cap136.21M
Revenue(TTM)8.07M
Net Income(TTM)-36.79M
Analysts84
Price Target4.08 (44.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.23%
EPS NY rev (3m)-1.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.89
P/FCF N/A
P/OCF N/A
P/B 2.68
P/tB 4.51
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.17
BVpS1.06
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.49%
ROE -72.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.73%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-15.02%
ROE(3y)-30.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.82%
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 483.84%
Cap/Sales 391.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.68
Altman-Z -0.49
F-Score5
WACC7.44%
ROIC/WACCN/A
Cap/Depr(3y)957.78%
Cap/Depr(5y)2682.27%
Cap/Sales(3y)1925.18%
Cap/Sales(5y)13341.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.16%
EPS Next Y-6.77%
EPS Next 2Y11.86%
EPS Next 3Y12.93%
EPS Next 5YN/A
Revenue 1Y (TTM)209.99%
Revenue growth 3Y195.81%
Revenue growth 5YN/A
Sales Q2Q%177.45%
Revenue Next Year111.33%
Revenue Next 2Y290.88%
Revenue Next 3Y183.6%
Revenue Next 5Y129.95%
EBIT growth 1Y-10.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.36%
EBIT Next 3Y31.11%
EBIT Next 5Y27.12%
FCF growth 1Y-65.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.71%
OCF growth 3YN/A
OCF growth 5YN/A

LHYFE SAS / LHYFE.PA FAQ

Can you provide the ChartMill fundamental rating for LHYFE SAS?

ChartMill assigns a fundamental rating of 2 / 10 to LHYFE.PA.


What is the valuation status of LHYFE SAS (LHYFE.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to LHYFE SAS (LHYFE.PA). This can be considered as Overvalued.


What is the profitability of LHYFE stock?

LHYFE SAS (LHYFE.PA) has a profitability rating of 1 / 10.


Can you provide the financial health for LHYFE stock?

The financial health rating of LHYFE SAS (LHYFE.PA) is 2 / 10.